Levophenacylmorphan
From Wikipedia, the free encyclopedia
 | |
|---|---|
| Systematic (IUPAC) name | |
| (-)-3-Hydroxy-N-phenacylmorphinan | |
| Clinical data | |
| Legal status | Schedule I (US) |
| Identifiers | |
| CAS number | 10061-32-2  |
| ATC code | None |
| PubChem | CID 5362482 |
| UNII | 7Q24AL2BR2  |
| Synonyms | Levophenacylmorphan |
| Chemical data | |
| Formula | C24H27NO2 |
| Mol. mass | 361.48 g/mol |
| SMILES
| |
| (what is this?) (verify) | |
Levophenacylmorphan is a morphinan derivative that acts as an opioid agonist. It has potent analgesic effects and is around 10x more potent than morphine.[1] Adverse effects associated with its use are those of the opioids as a whole, including pruritus, nausea, respiratory depression, euphoria and development of tolerance and dependence to its effects.[2]
References
- ↑ MAY, E.L. & EDDY, N.B., A New Potent Synthetic Analgesic, J. Org. Chem., 24 : 294, 1959.
- ↑ Fraser HF, Isbell H. Human pharmacology and addiction liabilities of phenazocine and levophenacylmorphan. UN Bulletin on Narcotics. 1960 Issue 2
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.